SuperworthBoston Scientific profit margin BSX
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 17.5%
- Operating margin, 12 months
- 19.8%
- Net margin on a year earlier
- +4.0 pts
- Peer median
- 14.2%
Over the twelve months to Jun 30, 2026, Boston Scientific kept 17.5% of its revenue as net profit, with an operating margin of 19.8% and a gross margin of 69.9%.
Five years earlier its net margin was 5.2%.
The median for 7 medical device stocks of a similar size is 14.2%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 14.4% | 18.0% | 69.0% |
| FY2024 | 11.1% | 15.5% | 68.6% |
| FY2023 | 11.2% | 16.5% | 69.5% |
| FY2022 | 5.3% | 13.0% | 68.8% |
| FY2021 | 8.8% | 10.1% | 68.8% |
| FY2020 | −0.8% | −0.8% | 65.0% |
| FY2019 | 43.8% | 14.1% | 71.0% |
| FY2018 | 17.0% | 15.3% | 71.4% |
| FY2017 | 1.1% | 14.2% | 71.3% |
| FY2016 | 4.1% | 5.3% | 71.1% |
| FY2015 | −3.2% | −4.4% | 71.0% |
| FY2014 | −1.6% | −4.1% | 70.1% |
| FY2013 | −1.7% | 1.7% | 69.6% |
| FY2012 | −56.1% | −53.4% | 67.6% |
| FY2011 | 5.8% | 11.8% | 65.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 17.5% | +4.0 pts | 19.8% | |
| Q1 FY26 | 17.3% | +5.7 pts | 18.4% | |
| Q4 FY25 | 14.4% | +3.4 pts | 18.0% | |
| Q3 FY25 | 14.4% | +3.2 pts | 17.9% | |
| Q2 FY25 | 13.5% | +1.5 pts | 17.0% | |
| Q1 FY25 | 11.6% | −0.5 pts | 16.2% | |
| Q4 FY24 | 11.1% | −0.1 pts | 15.5% | |
| Q3 FY24 | 11.3% | +2.3 pts | 15.8% | |
| Q2 FY24 | 12.0% | +5.2 pts | 16.2% | |
| Q1 FY24 | 12.1% | +5.2 pts | 16.8% | |
| Q4 FY23 | 11.2% | +5.9 pts | 16.5% | |
| Q3 FY23 | 8.9% | +3.9 pts | 15.7% |
Against its peers
Companies in Medical - Devices nearest Boston Scientific's size, closest first, today.
| Company | Profit margin |
|---|---|
| BSXBoston Scientific | 17.5% |
| EWEdwards Lifesciences | 15.4% |
| SYKStryker | 14.4% |
| MDTMedtronic | 13.9% |
| GEHCGE HealthCare Technologies | 9.3% |
| DXCMDexCom | 20.1% |
| ABTAbbott Laboratories | n/m |
| ZBHZimmer Biomet | 9.5% |
| Peer median | 14.2% |
Where Boston Scientific ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Boston Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.